Capecitabine
Showing 1 - 25 of 2,086
Colorectal Cancer, Colorectal Cancer Stage IV Trial (Fruquintinib Plus Capecitabine, Capecitabine)
Not yet recruiting
- Colorectal Cancer
- Colorectal Cancer Stage IV
- Fruquintinib Plus Capecitabine
- Capecitabine
- (no location specified)
Jul 9, 2022
Recurrent Metastatic Nasopharyngeal Carcinoma Trial (Mitoxantrone HCl liposome injection, Capecitabine)
Not yet recruiting
- Recurrent Metastatic Nasopharyngeal Carcinoma
- Mitoxantrone hydrochloride liposome injection
- Capecitabine
- (no location specified)
Jan 29, 2023
Metastatic Colorectal Cancer Trial in Guangzhou (Fruquintinib alternating with Bevacizumab plus Capecitabine, Bevacizumab plus
Recruiting
- Metastatic Colorectal Cancer
- Fruquintinib alternating with Bevacizumab plus Capecitabine
- Bevacizumab plus Capecitabine
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Jan 4, 2023
Breast Tumors, Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (Taxane plus Intermittent Capecitabine, Utidelone
Not yet recruiting
- Breast Neoplasms
- Locally Advanced or Metastatic Breast Cancer
- Taxane plus Intermittent Capecitabine
- +3 more
-
Guangzhou, Guangdong, ChinaShusen Wang
Dec 27, 2021
Metastatic Pancreatic Adenocarcinoma Trial (Ivaltinostat, Capecitabine)
Not yet recruiting
- Metastatic Pancreatic Adenocarcinoma
- Ivaltinostat
- Capecitabine
- (no location specified)
Feb 10, 2022
Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)
Recruiting
- Metastatic Colorectal Cancer
- Cetuximab
- Capecitabine
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023
Metastatic HER2 Negative Breast Carcinoma, Brain Metastases, Capecitabine Trial in Changsha (UTD1 combined with capecitabine)
Recruiting
- Metastatic HER2 Negative Breast Carcinoma
- +3 more
- UTD1 combined with capecitabine
-
Changsha, ChinaQuchang Ouyang
Sep 9, 2022
Advanced Breast Cancer Trial (Dalpiciclib+ letrozole +capecitabine)
Not yet recruiting
- Advanced Breast Cancer
- Dalpiciclib+ letrozole +capecitabine
- (no location specified)
Jul 21, 2022
Breast Cancer Trial in Beijing (oral vinorelbine and capecitabine)
Recruiting
- Breast Cancer
- oral vinorelbine and capecitabine
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Feb 27, 2023
Nasopharyngeal Carcinoma Trial in Guangzhou (Sintilimab, Capecitabine)
Recruiting
- Nasopharyngeal Carcinoma
- Sintilimab
- Capecitabine
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 5, 2022
Pseudomyxoma Peritonei Trial in Milano (Capecitabine)
Recruiting
- Pseudomyxoma Peritonei
- Capecitabine
-
Milano, MI, ItalyFondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 4, 2022
Hormone Receptor-positive Breast Cancer Trial in Tampa (Cemiplimab, Capecitabine)
Recruiting
- Hormone Receptor-positive Breast Cancer
- Cemiplimab
- Capecitabine
-
Tampa, FloridaMoffitt Cancer Center
Jul 27, 2022
Cholangiocarcinoma, Intrahepatic Trial in Shanghai (Capecitabine, PD-1 Antibody(Tislelizumab))
Recruiting
- Cholangiocarcinoma, Intrahepatic
- Capecitabine
- PD-1 Antibody(Tislelizumab)
-
Shanghai, ChinaLulu@Huashan.Org.Cn
Aug 16, 2022
Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,
Recruiting
- Biliary Tract Cancer (CCA)
- +4 more
- Durvalumab
- +2 more
-
Frankfurt am Main, GermanyKrankenhaus Nordwest
Jun 23, 2022
Radiotherapy, PD-1 Inhibitor, Capecitabine Trial in Zhuhai (SBRT radiotherapy + Conventionally fractionated radiotherapy, PD-1
Recruiting
- Radiotherapy
- +3 more
- SBRT radiotherapy + Conventionally fractionated radiotherapy
- +2 more
-
Zhuhai, Guangdong, ChinaFifth Affilliated Hospital of Sun Yat-sen University
Apr 13, 2022
Metastatic Nasopharyngeal Carcinoma Trial (Capecitabine plus toripalimab)
Not yet recruiting
- Metastatic Nasopharyngeal Carcinoma
- Capecitabine plus toripalimab
- (no location specified)
Jul 30, 2022
Metastatic Colorectal Cancer Trial in Beijing (fruquintinib plus capecitabine)
Recruiting
- Metastatic Colorectal Cancer
- fruquintinib plus capecitabine
-
Beijing, ChinaNational Center/Cancer Hospital, China Academy of Medical Scienc
Aug 17, 2022
Colorectal Cancer Metastatic, Peritoneal Carcinomatosis Trial in Amsterdam (Galunisertib plus capecitabine)
Not yet recruiting
- Colorectal Cancer Metastatic
- Peritoneal Carcinomatosis
- Galunisertib plus capecitabine
-
Amsterdam, Netherlands
- +1 more
Jan 17, 2023
Metastatic Colorectal Cancer Trial (Anti-PD-1 Monoclonal Antibody + Capecitabine)
Not yet recruiting
- Metastatic Colorectal Cancer
- Anti-PD-1 Monoclonal Antibody + Capecitabine
- (no location specified)
Apr 30, 2022
Hand and Foot Syndrome, Erythrodysesthesia Syndrome, HFS Trial in Tanta (Celecoxib 200mg, Capecitabine-based chemo)
Recruiting
- Hand and Foot Syndrome
- +3 more
- Celecoxib 200mg
- Capecitabine-based chemotherapy
-
Tanta, EgyptFaculty of Pharmacy-Tanta University
Apr 7, 2022
Unresectable Metastatic Colorectal Cancer Trial in Beijing (fruquintinib plus capecitabine)
Recruiting
- Unresectable Metastatic Colorectal Cancer
- fruquintinib plus capecitabine
-
Beijing, ChinaBeijing Friendship Hospital
Aug 17, 2022
Capecitabine Versus S-1 as Adjuvant Therapy in Biliary Tract
Recruiting
- Biliary Tract Neoplasms
- +3 more
- S-1
- Capecitabine
-
Shanghai, ChinaHuashan hospital
Aug 16, 2022
Gastroesophageal Junction Adenocarcinoma Trial in Shijiazhuang (Oxaliplatin; Capecitabine, Oxaliplatin; Capecitabine; concurrent
Completed
- Gastroesophageal Junction Adenocarcinoma
- Oxaliplatin; Capecitabine
- Oxaliplatin; Capecitabine; concurrent radiotherapy
-
Shijiazhuang, Hebei, ChinaDepartment of General Surgery
Feb 4, 2022
Breast Cancer Trial (Capecitabine and Neratinib.)
Not yet recruiting
- Breast Cancer
- Capecitabine and Neratinib.
- (no location specified)
Jul 8, 2022